BR9810197A - Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto - Google Patents

Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto

Info

Publication number
BR9810197A
BR9810197A BR9810197-8A BR9810197A BR9810197A BR 9810197 A BR9810197 A BR 9810197A BR 9810197 A BR9810197 A BR 9810197A BR 9810197 A BR9810197 A BR 9810197A
Authority
BR
Brazil
Prior art keywords
product
compounds
pharmaceutical composition
preparation process
preparation
Prior art date
Application number
BR9810197-8A
Other languages
English (en)
Other versions
BR9810197B1 (pt
Inventor
Jeremiah Harnett
Dennis Bigg
De Lassauniere Pierre Chabrier
Serge Auvin
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of BR9810197A publication Critical patent/BR9810197A/pt
Publication of BR9810197B1 publication Critical patent/BR9810197B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

''PRODUTO, COMPOSTOS, PROCESSO DE PREPARAçãO DESTES, COMPOSIçãO FARMACêUTICA, E, UTILIZAçãO DE UM PRODUTO'' A invenção tem por objeto derivados inéditos da 2-(iminometil)amino-fenila, seus processos de preparação, sua aplicação como droga e as composições farmacêuticas que os contêm.
BRPI9810197-8A 1997-06-20 1998-06-15 produto étil como medicamento, compostos, processo de preparaÇço destes, composiÇço farmacÊutica, e, utilizaÇço de um produto. BR9810197B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9707701A FR2764889B1 (fr) 1997-06-20 1997-06-20 Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR97/07701 1997-06-20
PCT/FR1998/001250 WO1998058934A1 (fr) 1997-06-20 1998-06-15 Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
BR9810197A true BR9810197A (pt) 2000-08-08
BR9810197B1 BR9810197B1 (pt) 2010-02-09

Family

ID=9508226

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9810197-8A BR9810197B1 (pt) 1997-06-20 1998-06-15 produto étil como medicamento, compostos, processo de preparaÇço destes, composiÇço farmacÊutica, e, utilizaÇço de um produto.

Country Status (29)

Country Link
EP (1) EP0991654B1 (pt)
JP (1) JP2002507965A (pt)
KR (2) KR100618478B1 (pt)
CN (1) CN1195762C (pt)
AR (1) AR012250A1 (pt)
AT (1) ATE297935T1 (pt)
AU (1) AU737964B2 (pt)
BR (1) BR9810197B1 (pt)
CA (1) CA2294809C (pt)
CZ (1) CZ299237B6 (pt)
DE (1) DE69830584T2 (pt)
DK (1) DK0991654T3 (pt)
ES (1) ES2244068T3 (pt)
FR (1) FR2764889B1 (pt)
HK (1) HK1030218A1 (pt)
HU (1) HUP0002425A3 (pt)
IL (1) IL133223A (pt)
MY (1) MY123193A (pt)
NO (1) NO315321B1 (pt)
NZ (1) NZ501656A (pt)
PL (1) PL191987B1 (pt)
PT (1) PT991654E (pt)
RU (1) RU2202543C2 (pt)
SK (1) SK286911B6 (pt)
TR (1) TR199903175T2 (pt)
TW (1) TW422842B (pt)
UA (1) UA70921C2 (pt)
WO (1) WO1998058934A1 (pt)
ZA (1) ZA985392B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
WO2000008018A1 (fr) * 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Derives de benzothiepine, leur procede de preparation et leurs utilisations
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2798127A1 (fr) 1999-09-03 2001-03-09 Expansia Sa Nouveau procede de preparation d'amidines derivees de l'acide 6-hydroxy-2,5,7,8-tetramethylchrommane-2-carboxy- lique
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
RU2380362C2 (ru) * 1999-10-11 2010-01-27 Сосьете Де Консей Де Решерш З Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
FR2799461B1 (fr) * 1999-10-11 2002-01-04 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
SE9904676D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
SE9904677D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
GB0019006D0 (en) * 2000-08-04 2000-09-20 Astrazeneca Ab Novel compounds
WO2002020511A1 (en) * 2000-09-05 2002-03-14 Astrazeneca Ab Amidine derivatives which are inhibitors of nitric oxide synthase
TWI248438B (en) * 2001-04-10 2006-02-01 Sod Conseils Rech Applic Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
CA2450589C (en) * 2001-06-08 2011-12-20 Cytokine Pharmasciences, Inc. Isoxazoline compounds having mif antagonist activity
HU228783B1 (en) * 2001-07-26 2013-05-28 Greenearth Cleaning Dry cleaning apparatus and method capable of utilizing a siloxane solvent
US7141561B2 (en) 2002-07-25 2006-11-28 Sanofi-Aventis Deutschland Gmbh Substituted diaryl heterocycles, process for their preparation and their use as medicaments
FR2842808B1 (fr) * 2002-07-25 2004-09-10 Sod Conseils Rech Applic Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
BRPI0507818A (pt) * 2004-03-26 2007-07-10 Cytokine Pharmasciences Inc composto e métodos de inibição
WO2006022442A1 (ja) * 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
JP5380069B2 (ja) * 2005-03-11 2014-01-08 ハワード フローリー インスティチュート フラボノイド化合物およびその使用
CA2773038A1 (en) 2009-09-04 2011-03-10 P. Jeffrey Conn Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US9051296B2 (en) 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
LT2872497T (lt) * 2012-07-12 2017-04-25 Khondrion Ip B.V. Chromanilo dariniai, skirti mitochondrinių ligų gydymui

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
WO1995005363A1 (en) * 1993-08-12 1995-02-23 Astra Aktiebolag Amidine derivatives with nitric oxide synthetase activities
ES2137512T3 (es) * 1994-05-07 1999-12-16 Astra Ab Derivados de amidina biciclicos como inhibidores de la sintetasa de oxido nitrico.

Also Published As

Publication number Publication date
NZ501656A (en) 2001-12-21
ATE297935T1 (de) 2005-07-15
ES2244068T3 (es) 2005-12-01
TW422842B (en) 2001-02-21
CA2294809A1 (fr) 1998-12-30
CZ299237B6 (cs) 2008-05-28
PL191987B1 (pl) 2006-07-31
KR20010013983A (ko) 2001-02-26
SK286911B6 (sk) 2009-07-06
CZ459799A3 (cs) 2000-07-12
CA2294809C (fr) 2010-02-02
JP2002507965A (ja) 2002-03-12
SK179699A3 (en) 2000-05-16
HUP0002425A1 (hu) 2001-11-28
WO1998058934A1 (fr) 1998-12-30
AR012250A1 (es) 2000-09-27
KR20050098970A (ko) 2005-10-12
HUP0002425A3 (en) 2001-12-28
AU737964B2 (en) 2001-09-06
NO996208L (no) 2000-02-15
IL133223A (en) 2004-09-27
FR2764889A1 (fr) 1998-12-24
DK0991654T3 (da) 2005-10-17
CN1264385A (zh) 2000-08-23
UA70921C2 (uk) 2004-11-15
DE69830584D1 (de) 2005-07-21
NO996208D0 (no) 1999-12-15
MY123193A (en) 2006-05-31
HK1030218A1 (en) 2001-04-27
CN1195762C (zh) 2005-04-06
FR2764889B1 (fr) 2000-09-01
IL133223A0 (en) 2001-03-19
KR100618478B1 (ko) 2006-09-01
RU2202543C2 (ru) 2003-04-20
KR100545946B1 (ko) 2006-01-26
EP0991654A1 (fr) 2000-04-12
TR199903175T2 (xx) 2000-04-21
NO315321B1 (no) 2003-08-18
EP0991654B1 (fr) 2005-06-15
DE69830584T2 (de) 2006-03-16
BR9810197B1 (pt) 2010-02-09
PL337499A1 (en) 2000-08-28
PT991654E (pt) 2005-10-31
ZA985392B (en) 1999-01-20
AU8218998A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
BR9810197A (pt) Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto
BR9808427A (pt) Produto, processo de preparação e utilização do mesmo e composição farmacêutica
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
DZ2880A1 (fr) Dérivés de quinoléine-2-one à substituant alcynylenouveaux procédé pour leur préparation et composi tions pharmaceutiques les contenant.
AR014261A1 (es) Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
MA26532A1 (fr) Derives d'amines cycliques, compositions pharmaceutiques les contenant, procede pour les preparer, et leur utilisation et tant que principe pharmaceutique agissant contre les maladies respiratoires.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
TR200101412T2 (tr) Yeni bileşikler.
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
BR9909739A (pt) Benzotiadiazóis e derivados
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BRPI0410623A (pt) composto, processo para preparação de um composto, composição farmacêutica, e, utilização de um composto
EE03395B1 (et) Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0005392A (pt) Composição de dhea e processo
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
BR0308201A (pt) Derivados de quinolina

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: C07D 333/04, C07D 311/00, C07D 207/34, C07D 207/16, C07D 211/70, C07D 205/04, C07D 401/00, C07D 409/12, C07D 409/14, C07D 413/12, C07D 417/12, C07D 233/78, C07D 261/06, C07D 277/04, C07D 277/06, C07D 277/14, C07D 277/20, C07D 307/68, A61K 31/33, A61K 31/38, A61K 31/381, A61K 31/395, A61K 31/40, A61K 31/4025, A61K 31/4178, A61K 31/426, A61K 31/427, A61K 31/44, A61K 31/445, A61K 31/45, A61K 31/453, A61K 31/4535, A61K 31/397, A61P 9/10, A61P 25/28, A61P 7/02, A61P 3/06, A61P 43/00

Ipc: C07D 333/04 (2008.01), C07D 311/00 (2008.01), C07D

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/02/2010, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2040 DE 09/02/2010, CODIGO DE DESPACHO 16.1, QUANTO AO NOME DO INVENTOR (72) POR TER SAIDO COM INCORRECAO.

B25D Requested change of name of applicant approved

Owner name: IPSEN PHARMA S.A.S. (FR)

B25G Requested change of headquarter approved

Owner name: IPSEN PHARMA S.A.S. (FR)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.